Colloid compositions for solid phase biomolecular analytical, preparative and identification systems
First Claim
1. A liquid composition comprisinga colloidal suspension of a biomolecule-binding matrix material uniformly dispersed in a liquid, wherein colloidal particles of said matrix material in said colloidal suspension are of a defined particle size of less than about 1 μ
- m in diameter, and wherein said biomolecule-binding matrix material is selected from the group consisting of nitrocellulose, polyvinyl difluoride and activated nylon;
replicate copies of a biologically active labeled biomolecule, wherein said biomolecules are distributed throughout said colloidal suspension and are bound to said matrix material particles and wherein said biomolecule is selected from the group consisting of a protein, peptide and oligopeptide;
one or more reference dyes distributed throughout said colloidal suspension; and
a blocking biomolecule, wherein said blocking biomolecule blocks sites on said biomolecule-binding matrix material not occupied by said biomolecule.
2 Assignments
0 Petitions
Accused Products
Abstract
A liquid composition comprising a colloidal suspension of a biomolecule-binding matrix material (preferably nitrocellulose) dispersed in a liquid, with particles of the matrix material being of a defined particle size, and replicate copies of a biomolecule, e.g., protein or nucleic acid probes, which are distributed, preferably uniformly, throughout the colloidal suspension and are bound to the matrix material particles, is disclosed. The liquid composition of the invention can be used directly for sample analysis or preparation of biomolecules, or aliquots of the composition can be spotted onto a support to form a microporous matrix system or microarray for analysis or preparation of biomolecules. Compositions and microarrays according to the invention are useful in any type of analytical or preparative procedure relating to biomolecules. They are particularly useful, e.g., in methods for detecting a biomolecule analyte in a liquid sample, methods for determining the presence of a particular nucleic acid sequence within a liquid sample and methods for determining the presence of a drug candidate molecule in a liquid sample. The invention further comprises kits for practicing the various methods of the invention.
-
Citations
13 Claims
-
1. A liquid composition comprising
a colloidal suspension of a biomolecule-binding matrix material uniformly dispersed in a liquid, wherein colloidal particles of said matrix material in said colloidal suspension are of a defined particle size of less than about 1 μ - m in diameter, and wherein said biomolecule-binding matrix material is selected from the group consisting of nitrocellulose, polyvinyl difluoride and activated nylon;
replicate copies of a biologically active labeled biomolecule, wherein said biomolecules are distributed throughout said colloidal suspension and are bound to said matrix material particles and wherein said biomolecule is selected from the group consisting of a protein, peptide and oligopeptide;
one or more reference dyes distributed throughout said colloidal suspension; and
a blocking biomolecule, wherein said blocking biomolecule blocks sites on said biomolecule-binding matrix material not occupied by said biomolecule. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)
- m in diameter, and wherein said biomolecule-binding matrix material is selected from the group consisting of nitrocellulose, polyvinyl difluoride and activated nylon;
Specification